CTA
GILD icon

Chesley Taft & Associates’s Gilead Sciences GILD Stock Holding History

Chesley Taft & Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$920K Sell
7,280
-55
-0.7% -$7.25K 0.04% 235
2026
Q1 		$1.02M Buy
7,335
+374
+5% +$52.4K 0.04% 216
2025
Q4 		$854K Buy
6,961
+2,156
+45% +$262K 0.03% 240
2025
Q3 		$533K Buy
4,805
+1,531
+47% +$174K 0.02% 258
2025
Q2 		$363K Buy
3,274
+974
+42% +$104K 0.02% 282
2025
Q1 		$258K Buy
+2,300
New +$237K 0.01% 311
2017
Q4 		– Sell
-5,000
Closed -$405K – 286
2017
Q3 		$405K Buy
5,000
+1,840
+58% +$141K 0.04% 233
2017
Q2 		$224K Sell
3,160
-200
-6% -$13.3K 0.02% 264
2017
Q1 		$228K Sell
3,360
-245
-7% -$17.2K 0.02% 261
2016
Q4 		$258K Sell
3,605
-845
-19% -$62.8K 0.03% 251
2016
Q3 		$352K Sell
4,450
-12,405
-74% -$1.01M 0.04% 218
2016
Q2 		$1.41M Sell
16,855
-275
-2% -$24.4K 0.14% 124
2016
Q1 		$1.57M Sell
17,130
-88,411
-84% -$7.97M 0.17% 114
2015
Q4 		$10.7M Sell
105,541
-59,280
-36% -$6.17M 1.12% 25
2015
Q3 		$16.2M Buy
164,821
+600
+0.4% +$66.6K 1.77% 13
2015
Q2 		$19.2M Buy
164,221
+3,780
+2% +$413K 1.96% 9
2015
Q1 		$15.7M Buy
160,441
+30,586
+24% +$3.11M 1.62% 15
2014
Q4 		$12.2M Sell
129,855
-14,250
-10% -$1.47M 1.24% 25
2014
Q3 		$15.3M Sell
144,105
-162
-0.1% -$15.9K 1.61% 12
2014
Q2 		$12M Buy
144,267
+9,655
+7% +$752K 1.24% 22
2014
Q1 		$9.54M Sell
134,612
-1,650
-1% -$129K 1.02% 32
2013
Q4 		$10.2M Buy
136,262
+3,775
+3% +$263K 1.02% 31
2013
Q3 		$8.33M Buy
132,487
+8,762
+7% +$524K 0.91% 37
2013
Q2 		$6.34M Buy
+123,725
New +$6.45M 0.74% 42

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Chesley Taft & Associates's GILD Position: Q2 2026 in Review

Chesley Taft & Associates reduced its Gilead Sciences (GILD) stake by 0.75% in Q2 2026, selling an estimated $7.25K and leaving 7,280 shares worth $920K. The position accounts for 0.04% of the portfolio, ranked #235.

Chesley Taft & Associates first reported a position in GILD in Q2 2013 and has held it in 24 quarters since. The position peaked at $19.2M in Q2 2015. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Chesley Taft & Associates held 7,280 shares of Gilead Sciences worth $920K as of Q2 2026.
  • Chesley Taft & Associates sold 55 Gilead Sciences shares in Q2 2026, an estimated $7.25K.
  • Gilead Sciences made up 0.04% of Chesley Taft & Associates's portfolio in Q2 2026, its #235 holding.
  • Chesley Taft & Associates first reported a position in Gilead Sciences in Q2 2013 and has held it in 24 quarters since.
  • Chesley Taft & Associates's Gilead Sciences position peaked at $19.2M in Q2 2015.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Chesley Taft & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.